Epidermal Growth Factor Receptor-Targeting Peptide Nanoparticles Simultaneously Deliver Gemcitabine and Olaparib To Treat Pancreatic Cancer with <i>Breast Cancer 2</i> (<i>BRCA2</i>) Mutation
Chong Du(Second Affiliated Hospital of Xi'an Jiaotong University), Yinmo Yang(Peking University), Xuexiang Han(Center for Excellence in Molecular Cell Science), Yingqiu Qi(Zhengzhou University), Jiayan Lang(National Center for Nanoscience and Technology), Guangjun Nie(National Center for Nanoscience and Technology), Zhengkui Zhang(Peking University), Huan Min(Zhengzhou University), Gregory J. Anderson(The University of Queensland), Xiaodong Tian(Peking University), Quanwei Shi(National Center for Nanoscience and Technology), Yazhou Wang(Hainan Modern Women and Children's Hospital), Ying Zhao(National Center for Nanoscience and Technology), Hao Qin(National Center for Nanoscience and Technology), Yinlong Zhang(National Center for Nanoscience and Technology), Xiao Zhao(Chinese Academy of Sciences)
Cited by 99
Related Papers
An ionizable lipid toolbox for RNA delivery
|Nature Communications|2021|581
Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology
|Nature Communications|2021|449
Precise nanomedicine for intelligent therapy of cancer
|Science China Chemistry|2018|413
Biomimetic Metal–Organic Framework Nanoparticles for Cooperative Combination of Antiangiogenesis and Photodynamic Therapy for Enhanced Efficacy
|Advanced Materials|2019|396
Reversal of pancreatic desmoplasia by re-educating stellate cells with a tumour microenvironment-activated nanosystem
|Nature Communications|2018|331